Sci Show: The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study. MK-4482, delivered orally, is now in human clinical trials.

Saturday, April 17, 2021

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study. MK-4482, delivered orally, is now in human clinical trials.

https://ift.tt/32kvabR via /r/science https://ift.tt/2Q9C2GI

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)